Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Net Margin (2016 - 2025)

Abeona Therapeutics has reported Net Margin over the past 12 years, most recently at 396.48% for Q4 2025.

  • For Q4 2025, Net Margin changed N/A year-over-year to 396.48%; the TTM value through Dec 2025 reached 1288.95%, changed N/A, while the annual FY2025 figure was 1152.53%, N/A changed from the prior year.
  • Net Margin for Q4 2025 was 396.48% at Abeona Therapeutics, down from 28416.75% in the prior quarter.
  • Over five years, Net Margin peaked at 28416.75% in Q2 2025 and troughed at 10408.82% in Q4 2022.
  • A 3-year average of 1723.13% and a median of 631.86% in 2023 define the central range for Net Margin.
  • On a YoY basis, Net Margin climbed as much as 31207bps in 2023 and fell as far as 31207bps in 2023.
  • Year by year, Net Margin stood at 10408.82% in 2022, then skyrocketed by 95bps to 475.83% in 2023, then grew by 17bps to 396.48% in 2025.
  • Business Quant data shows Net Margin for ABEO at 396.48% in Q4 2025, 28416.75% in Q2 2025, and 475.83% in Q2 2023.